Summary
David Wright is a CTO and founder with 12 years' experience at the interface of computational chemistry, molecular simulation and machine learning, currently leading Kuano's development of AI- and quantum-enabled drug design platforms. He has a strong academic foundation (PhD, UCL) and a track record of translating research into cloud and HPC-delivered tools—having led development of BAC and EasyVVUQ and commercialized simulation SaaS at EnsembleMD. His work spans atomistic-to-multiscale modelling applied to HIV and cancer targets, combining free energy calculations, QM/MD and uncertainty quantification to predict drug binding and resistance. Equally comfortable as a researcher, software engineer and technical leader, he routinely integrates experimental data (e.g. SAXS/SANS) with large-scale simulations to generate actionable insights. Based in London, he brings a rare blend of domain depth and product focus, turning complex physical simulation workflows into robust, production-ready platforms.
12 years of coding experience
8 years of employment as a software developer
Master of Physics (MPhys) Computational Physics, Master of Physics (MPhys) Computational Physics at University of York
University College London